In 20 patients with mild to moderate essential hypertension, serum ionized calcium was determined before and after four weeks of treatment with 240 mg verapamil sustained release bid. Pretreatment systolic blood pressure was inversely correlated to serum ionized calcium (r = — 0.44, p = 0.05). Mean blood pressure was significantly (p < 0.001) reduced (from 161/100 to 145/88 mm Hg), but mean serum ionized calcium did not change during treatment (from 1.23 to 1.24 mmol/L).
A significant inverse correlation (r = -0.56, p = 0.01) was found between pretreatment serum ionized calcium and reduction in systolic blood pressure during verapamil treatment. Thus serum ionized calcium in untreated essential hypertensive patients may predict the blood pressure response to the slow calcium channel blocker verapamil.
Get full access to this article
View all access options for this article.
References
1.
Bolton TB: Mechanisms of action of transmitters and other substances on smooth muscle . Physiol Rev59:606-718, 1979.
2.
Fleckenstein A.: Calcium antagonism in heart and smooth muscle. Experimental facts and therapeutic prospects. New York: John Wiley & Sons, 1983, pp. 209-212.
3.
Swales JD: Ion transport in hypertension. Biosci Rep2:967-990, 1982.
4.
Postnov YV, Orlov SN: Cell membrane alteration as a source of primary hypertension. J Hypertension2:1-6, 1984.
5.
Robinson BF: Altered calcium handling as a cause of primary hypertension. J Hypertension2:453-460, 1984.
6.
McCarron DA: Low serum concentrations of ionized calcium in patients with hypertension . N Engl J Med307:226-228, 1982.
7.
Resnick LM, Laragh JH, Sealey JE, Alderman MH: Divalent cations in essential hypertension. Relations between serum ionized calcium magnesium, and plasma renin activity. N Engl J Med309:888-891, 1983.
8.
Resnick LM, Nicholson JP, Laragh JH: Calcium metabolism and renin-aldosterone system in essential hypertension . J Cardiovasc Pharmacol7(Suppl 6):S187-S193, 1985.
9.
Fogh-Andersen N.: Ionized calcium analyzer with a built-in pH correction. Clin Chem27:1264-1267, 1981 .
10.
Winer BJ: Statistical Principles in Experimental Design, 2nd ed. New York: McGraw-Hill, 1971.
11.
Lewis Grj, Morley KD, Lewis BM, Bones PJ: The treatment of hypertension with verapamil. N Z Med J87:351-354, 1978.
12.
Midtbø K., Hals O., van der Meer J., Storstein L., Lauve O.: Instant and sustained release verapamil in the treatment of essential hypertension . Am J Cardiol57:59D-63D, 1986.
13.
Singer Drj, Markandu ND, Cappuccio FP, Beynon GW, et al: Does oral calcium lower blood pressure: A double-blind study . J Hypertension3:661, 1985.
14.
Fray Jcs: Stimulus-secretion coupling of renin: Role of haemodynamic and other factors . Circ Res47:485-492, 1980.
15.
Braunwald E. : Mechanism of action of calcium-channel-blocking agents. N Engl J Med307:1618-1627, 1982 .
16.
Zidek W., Losse H., Vetter H.: Effect of nifedipine on blood pressure and on intracellular calcium in arterial hypertension. J Cardiovasc Pharmacol4:S303-S305, 1982.
17.
Ericsson F. : Effect of nifedipine on cellular electrolytes in fourteen patients with untreated primary hypertension. Acta Med Scand218:69-72, 1985.
18.
Erne P., Bolli P., Burgisser E., Bühler FR: Correlation of platelet calcium and blood pressure: Effect of hypertensive therapy. N Engl J Med310:1084-1088, 1984 .
19.
Baudouin M. , Meyer P., Fermandjian S., Morgat J-L.: Calcium release induced by interaction of angiotensin with its receptors in smooth muscle cell microsomes. Nature235:336-338, 1972.
